Treatment preferences between survival and quality of life and their association with clinical outcomes in older adults with advanced cancer. Rates of first NGS relative to the time of death (in pts ...
THETFORD MINES, QC, Dec. 22, 2025 /CNW/ – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), a leader in innovative ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
The race for early cancer detection is one that physicians have been running for millennia. In one of humanity’s oldest surviving medical texts, the ancient Egyptian physician Imhotep described 46 ...
India's hospital chains, diagnostics networks, and global investors have poured millions of dollars into gene sequencing, ...
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes through targeted T-cell activation.
The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted therapies, the promise of off-the-shelf chimeric antigen receptor (CAR) ...
MedPage Today on MSN
Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...
According to MarketsandMarkets, The report Next-generation Sequencing Services Market is projected to grow from USD 3.80 billion in 2025 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback